Vaccines Get First Shot At Using Bar Code Alternatives As FDA Reconsiders Reg
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency seeks information on alternative technologies and the successes and challenges companies have faced in adopting linear bar codes for drug products.